Important Information About Bamlanivimab/Etesevimab
Due to the high frequency of the Omicron variant, bamlanivimab and etesevimab are not currently authorized in any U.S. region. Therefore, these drugs may not be administered for treatment or post-exposure prevention of COVID-19 under the Emergency Use Authorization until further notice by the FDA.
Bamlanivimab/Etesevimab FDA EUA Resources
